Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus

Author: Vesell E.S.   Beyer K.H.  

Publisher: Elsevier

ISSN: 0300-483X

Source: Toxicology, Vol.144, Iss.1, 2000-04, pp. : 5-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content